Nancy Capra

Ms. Capra has served as our Vice President of Program Management and Development Operations since February 2021. Prior to that, she had served as Executive Director of Program Management since November 2015. Ms. Capra is a Certified Project Management (CPM) professional with over 35 years of pharmaceutical drug development and leadership experience building cross-functional teams from early development through NDA submissions and post-marketing. Prior to joining ContraFect, Nancy spent 28 years at Merck Research Laboratories and gained direct experience across a wide range of functional areas including safety assessment, clinical pharmacology, pharmaceutical research and development, as well as program management. In this capacity, Ms. Capra was instrumental in the submission and approval of several NDAs including Invanz (carbapenem antibiotic), Cancidas (antifungal), and Bridion (neuromuscular blockade reversal agent NDA resubmission). In addition to program management, Ms. Capra served as Pipeline Lead for the neuroscience franchise spanning early discovery through commercial launch and life cycle management. Ms. Capra finished her career at Merck as the R&D Portfolio Manager directly accountable to the President of the Merck Research Laboratories.

Ms. Capra received her B.S. in Animal Husbandry from Delaware Valley University and is certified as a project management professional.